DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.2 HKD | -0.83% |
|
-0.83% | +14.29% |
| 03-25 | Dawnrays' 2023 Profit Falls 9% on Lower Revenue | MT |
| 03-22 | Dawnrays Pharmaceutical Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 233M | - | - | - | - | - | |
| 723B | ||||||
| 595B | ||||||
| 369B | ||||||
| 332B | ||||||
| 282B |
